164 related articles for article (PubMed ID: 22076477)
41. Development and validation of a risk score predicting risk of colorectal cancer.
Steffen A; MacInnis RJ; Joshy G; Giles GG; Banks E; Roder D
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2543-52. PubMed ID: 25087576
[TBL] [Abstract][Full Text] [Related]
42. An Australian risk prediction model for determining early mortality following aortic valve replacement.
Ariyaratne TV; Billah B; Yap CH; Dinh D; Smith JA; Shardey GC; Reid CM
Eur J Cardiothorac Surg; 2011 Jun; 39(6):815-21. PubMed ID: 21376618
[TBL] [Abstract][Full Text] [Related]
43. Derivation and validation of in-hospital mortality prediction models in ischaemic stroke patients using administrative data.
Lee J; Morishima T; Kunisawa S; Sasaki N; Otsubo T; Ikai H; Imanaka Y
Cerebrovasc Dis; 2013; 35(1):73-80. PubMed ID: 23429000
[TBL] [Abstract][Full Text] [Related]
44. A new framework to enhance the interpretation of external validation studies of clinical prediction models.
Debray TP; Vergouwe Y; Koffijberg H; Nieboer D; Steyerberg EW; Moons KG
J Clin Epidemiol; 2015 Mar; 68(3):279-89. PubMed ID: 25179855
[TBL] [Abstract][Full Text] [Related]
45. A systematic review of the status and methodological considerations for estimating risk of first ever stroke in the general population.
Xu W; Huang J; Yu Q; Yu H; Pu Y; Shi Q
Neurol Sci; 2021 Jun; 42(6):2235-2247. PubMed ID: 33783660
[TBL] [Abstract][Full Text] [Related]
46. Validating Breast Cancer Risk Prediction Models in the Korean Cancer Prevention Study-II Biobank.
Jee YH; Gao C; Kim J; Park S; Jee SH; Kraft P
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1271-1277. PubMed ID: 32245787
[TBL] [Abstract][Full Text] [Related]
47. Validation of risk assessment models for predicting the incidence of breast cancer in korean women.
Min JW; Chang MC; Lee HK; Hur MH; Noh DY; Yoon JH; Jung Y; Yang JH;
J Breast Cancer; 2014 Sep; 17(3):226-35. PubMed ID: 25320620
[TBL] [Abstract][Full Text] [Related]
48. Internal-external cross-validation helped to evaluate the generalizability of prediction models in large clustered datasets.
Takada T; Nijman S; Denaxas S; Snell KIE; Uijl A; Nguyen TL; Asselbergs FW; Debray TPA
J Clin Epidemiol; 2021 Sep; 137():83-91. PubMed ID: 33836256
[TBL] [Abstract][Full Text] [Related]
49. Risk prediction models for lung cancer: Perspectives and dissemination.
Tang W; Peng Q; Lyu Y; Feng X; Li X; Wei L; Li N; Chen H; Chen W; Dai M; Wu N; Li J; Huang Y
Chin J Cancer Res; 2019 Apr; 31(2):316-328. PubMed ID: 31156302
[TBL] [Abstract][Full Text] [Related]
50. A new concordance measure for risk prediction models in external validation settings.
van Klaveren D; Gönen M; Steyerberg EW; Vergouwe Y
Stat Med; 2016 Oct; 35(23):4136-52. PubMed ID: 27251001
[TBL] [Abstract][Full Text] [Related]
51. Independent external validation and comparison of prevalent diabetes risk prediction models in a mixed-ancestry population of South Africa.
Masconi K; Matsha TE; Erasmus RT; Kengne AP
Diabetol Metab Syndr; 2015; 7():42. PubMed ID: 25987905
[TBL] [Abstract][Full Text] [Related]
52. External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients.
van Kleef JJ; van den Boorn HG; Verhoeven RHA; Vanschoenbeek K; Abu-Hanna A; Zwinderman AH; Sprangers MAG; van Oijen MGH; De Schutter H; van Laarhoven HWM
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32244310
[TBL] [Abstract][Full Text] [Related]
53. Reclassification of predictions for uncovering subgroup specific improvement.
Biswas S; Arun B; Parmigiani G
Stat Med; 2014 May; 33(11):1914-27. PubMed ID: 24353130
[TBL] [Abstract][Full Text] [Related]
54. Re: Validation of the Gail et al. model for predicting individual breast cancer risk.
Bondy ML; Vogel VG
J Natl Cancer Inst; 1994 Sep; 86(17):1350. PubMed ID: 8093200
[No Abstract] [Full Text] [Related]
55. Agreement between breast cancer risk estimation methods.
McGuigan KA; Ganz PA; Breant C
J Natl Cancer Inst; 1996 Sep; 88(18):1315-7. PubMed ID: 8797772
[No Abstract] [Full Text] [Related]
56. Guidance on reporting multivariable regression models in CMI.
Leibovici L; Scudeller L; Kalil A; Huttner A; Leeflang MMG; Bielicki J; Allerberger F; Paul M; Rodríguez-Baño J
Clin Microbiol Infect; 2020 Jan; 26(1):1-2. PubMed ID: 31707134
[No Abstract] [Full Text] [Related]
57. External validation is only needed when prediction models are worth it (Letter commenting on: J Clin Epidemiol. 2015;68:25-34).
Martens FK; Kers JG; Janssens AC
J Clin Epidemiol; 2016 Jan; 69():249-50. PubMed ID: 25726454
[No Abstract] [Full Text] [Related]
58. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
59. Predicting and communicating the risk of recurrence and death in women with early-stage breast cancer: a systematic review of risk prediction models.
Engelhardt EG; Garvelink MM; de Haes JH; van der Hoeven JJ; Smets EM; Pieterse AH; Stiggelbout AM
J Clin Oncol; 2014 Jan; 32(3):238-50. PubMed ID: 24344212
[TBL] [Abstract][Full Text] [Related]
60. Risk factors of breast cancer: a systematic review and meta-analysis.
Anothaisintawee T; Wiratkapun C; Lerdsitthichai P; Kasamesup V; Wongwaisayawan S; Srinakarin J; Hirunpat S; Woodtichartpreecha P; Boonlikit S; Teerawattananon Y; Thakkinstian A
Asia Pac J Public Health; 2013 Sep; 25(5):368-87. PubMed ID: 23709491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
